Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis

Kroser, 2006, Drug therapy of inflammatory bowel disease in fertile women, Am J Gastroenterol, 101, S633, 10.1111/j.1572-0241.2006.00961.x Mottet, 2005, Pregnancy and Crohn's disease, Digestion, 71, 54, 10.1159/000083874 Klotz, 1985, Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid, Clin Pharmacokinet, 10, 285, 10.2165/00003088-198510040-00001 Diav-Citrin, 1998, The safety of mesalamine in human pregnancy: a prospective controlled cohort study, Gastroenterology, 114, 23, 10.1016/S0016-5085(98)70628-6 Norgard, 2003, Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study, Gut, 52, 243, 10.1136/gut.52.2.243 Moskovitz, 2004, The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients, Am J Gastroenterol, 99, 656, 10.1111/j.1572-0241.2004.04140.x Norgard, 2007, Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study, Am J Gastroenterol, 102, 1406, 10.1111/j.1572-0241.2007.01216.x Baiocco, 1984, The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome, J Clin Gastroenterol, 6, 211 Mogadam, 1981, Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome, Gastroenterology, 80, 72, 10.1016/0016-5085(81)90193-1 Willoughby, 1980, Ulcerative colitis and pregnancy, Gut, 21, 469, 10.1136/gut.21.6.469 Ida, 1999, Ulcerative colitis and pregnancy, Nippon Rinsho, 57, 2603 Trallori, 1994, 5-Aminosalicylic acid in pregnancy: clinical report, Ital J Gastroenterol, 26, 75 Habal, 1993, Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course, Gastroenterology, 105, 1057, 10.1016/0016-5085(93)90949-D Nielsen, 2007, Drug insight: aminosalicylates for the treatment of IBD, Nat Clin Pract Gastroenterol Hepatol, 4, 160, 10.1038/ncpgasthep0696 Marteau, 1998, Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules, Aliment Pharmacol Ther, 12, 1101, 10.1046/j.1365-2036.1998.00417.x Newman, 1983, Possible teratogenicity of sulphasalazine, Med J Aust, 1, 528, 10.5694/j.1326-5377.1983.tb136199.x Tennenbaum, 1999, Pregnancy outcome in inflammatory bowel diseases, Gastroenterol Clin Biol, 23, 464 Cornish, 2007, A meta-analysis on the influence of inflammatory bowel disease on pregnancy, Gut, 56, 830, 10.1136/gut.2006.108324 Katz, 2001, Inflammatory bowel disease and pregnancy, Inflamm Bowel Dis, 7, 146, 10.1097/00054725-200105000-00011 Connell, 1999, Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy, Drug Saf, 21, 311, 10.2165/00002018-199921040-00006 Rezaie, 2005, Biologic management of fistulizing Crohn's disease, Int J Pharmacol, 1, 17, 10.3923/ijp.2005.17.24 Rahimi, 2007, A meta-analysis of antibiotic therapy for active ulcerative colitis, Dig Dis Sci, 52, 2920, 10.1007/s10620-007-9760-1 Rahimi, 2006, A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn's disease, Clin Ther, 28, 1983, 10.1016/j.clinthera.2006.12.012 Elahi, 2007, On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials, Dig Dis Sci